NASDAQ:MYLMylan Stock Price, Forecast & News

Mylan's stock was trading at $14.47 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MYL stock has increased by 15.0% and is now trading at $16.64.
View which stocks have been most impacted by COVID-19.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mylan in the last year. There are currently 5 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Mylan.

Mylan is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Mylan.

Mylan NV (NASDAQ:MYL) issued its quarterly earnings results on Thursday, August, 6th. The company reported $1.11 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.95 by $0.16. The business earned $2.73 billion during the quarter, compared to analysts' expectations of $2.74 billion. Mylan had a return on equity of 20.43% and a net margin of 2.35%. The business's quarterly revenue was down 4.2% compared to the same quarter last year. During the same period last year, the business posted $1.03 EPS.
View Mylan's earnings history.

Mylan issued an update on its FY 2020 Pre-Market earnings guidance on Thursday, August, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $11.5-12 billion, compared to the consensus revenue estimate of $11.62 billion.

8 brokers have issued 1 year price targets for Mylan's shares. Their forecasts range from $17.00 to $27.00. On average, they expect Mylan's stock price to reach $20.67 in the next year. This suggests a possible upside of 24.2% from the stock's current price.
View analysts' price targets for Mylan.

News stories about MYL stock have trended somewhat negative recently, according to InfoTrie Sentiment. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Mylan earned a daily sentiment score of -1.2 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term.
View the latest news about Mylan.

Mylan saw a increase in short interest in May. As of May 15th, there was short interest totaling 27,660,000 shares, an increase of 20.5% from the April 30th total of 22,960,000 shares. Based on an average trading volume of 7,886,400 shares, the short-interest ratio is presently 3.5 days. Approximately 5.4% of the shares of the stock are sold short.
View Mylan's Short Interest.

Some companies that are related to Mylan include Johnson & Johnson (JNJ), Pfizer (PFE), Merck & Co., Inc. (MRK), AbbVie (ABBV), Eli Lilly And Co (LLY), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), Horizon Therapeutics (HZNP), Perrigo (PRGO), Jazz Pharmaceuticals (JAZZ), Nektar Therapeutics (NKTR), Pacira Biosciences (PCRX), Corcept Therapeutics (CORT) and Zogenix (ZGNX).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Mylan investors own include Gilead Sciences (GILD), Alibaba Group (BABA), Pfizer (PFE), Teva Pharmaceutical Industries (TEVA), Micron Technology (MU), NVIDIA (NVDA), Cisco Systems (CSCO), Intel (INTC), AbbVie (ABBV) and Starbucks (SBUX).

Mylan trades on the NASDAQ under the ticker symbol "MYL."

Mylan's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Pzena Investment Management LLC (3.24%), Bank of New York Mellon Corp (0.95%), Russell Investments Group Ltd. (0.63%), US Bancorp DE (0.56%), Swiss National Bank (0.39%) and Phoenix Holdings Ltd. (0.37%). Company insiders that own Mylan stock include Goulds Bruce, Melina E Higgins, Paul Campbell, Richard A Mark, Robert J Coury and Sjoerd S Vollebregt.
View institutional ownership trends for Mylan.

MYL stock was sold by a variety of institutional investors in the last quarter, including Pzena Investment Management LLC, First Trust Advisors LP, State of Wisconsin Investment Board, Retirement Systems of Alabama, Bank of New York Mellon Corp, Prudential Financial Inc., Robeco Institutional Asset Management B.V., and Jabodon PT Co..
View insider buying and selling activity for Mylan.

MYL stock was purchased by a variety of institutional investors in the last quarter, including US Bancorp DE, AJO LP, Russell Investments Group Ltd., State of Alaska Department of Revenue, SG Americas Securities LLC, Andra AP fonden, Achmea Investment Management B.V., and RMB Capital Management LLC. Company insiders that have bought Mylan stock in the last two years include Melina E Higgins, Richard A Mark, Robert J Coury, and Sjoerd S Vollebregt.
View insider buying and selling activity for Mylan.

Shares of MYL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of MYL stock can currently be purchased for approximately $16.64.

Mylan has a market capitalization of $8.60 billion and generates $11.50 billion in revenue each year. The company earns $16.80 million in net income (profit) each year or $4.42 on an earnings per share basis. Mylan employs 35,000 workers across the globe.

The official website for Mylan is www.mylan.com.

Mylan's mailing address is 1000 MYLAN BOULEVARD, CANONSBURG PA, 15317. The company can be reached via phone at 724-514-1800 or via email at [email protected]